CD274 and neoplasm: The PD-L1/PD-1 pathway of immune regulation is presently an important therapeutic focus in tumor immunotherapy, and although Cbl-b−/− mice have been shown to be resistant to several immuno-regulatory mechanisms, the sensitivity of Cbl-b−/− mice to PD-L1-mediated suppression has not been reported.